Acorda Therapeutics, Inc. ACOR NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

15/100

0/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Acorda Therapeutics, Inc. (ACOR) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 14/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

15/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

✗

未來

20/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

43/100

→ Income

✗

成长

15/100

→ Income

✗

收入

10/100

→ Income

估值概览 — ACOR

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.01

EV/EBITDA0.0

每股数据

EPS (TTM)$-203.59

每股账面价值$0.00

每股营收$94.71

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2014	$50.40	$401.48M	$17.67M	4.4%
2015	$30.00	$492.66M	$11.06M	2.2%
2016	$-91.79	$519.6M	$-34.62M	-6.7%
2017	$-583.20	$588.29M	$-223.36M	-38%
2018	$85.38	$471.43M	$33.68M	7.1%
2019	$-689.42	$192.41M	$-272.97M	-141.9%
2020	$-246.40	$152.97M	$-99.59M	-65.1%
2021	$-195.75	$129.07M	$-103.95M	-80.5%
2022	$-66.90	$118.57M	$-65.92M	-55.6%
2023	$-203.59	$117.63M	$-252.85M	-215%